title: Osteoporosis and treatments in Japan: management for preventing subsequent fractures.
abstract: Prevalent fractures are major contributors to an increased risk of subsequent fractures, particularly in people with osteoporosis. While many studies have been conducted to assess the incidence of fracture in Japanese people with osteoporosis, far fewer have been conducted to assess the risk of subsequent fractures. This article reviews the morbidity, mortality, and risk of fracture in patients who are at high risk of subsequent fracture in Japan and the current treatment options available for these patients. Osteoporotic fractures in Japan are associated with high morbidity and mortality that result in significant financial and social costs. The rise in the proportion of elderly women in the Japanese population is contributing to a greater proportion of people with osteoporotic fractures and the high cost of osteoporosis. Although hip fractures have a significant effect on costs, a greater proportion of the Japanese population experience vertebral fractures. An increase in the incidence of vertebral fractures is concerning because preexisting vertebral fractures in older patients are associated with an increased risk of subsequent fractures. Hence, there is a clear rationale for pharmacological treatment of patients with prevalent vertebral fractures, or for those who are hospitalized or undergo surgery for osteoporotic fractures. Several pharmacological therapies are now available in Japan for the treatment of patients with osteoporosis. Understanding the consequences of subsequent fractures and the treatment options available for patients at high risk of subsequent fractures may contribute to clinical decision-making and improved outcomes for patients with osteoporosis.
authors.affiliation: Japan Health Technology Assessment, Eli Lilly Japan K.K., Sannomiya Plaza Building, 7-1-5, Isogamidori, Chuo-ku, Kobe, 651-0086, Japan. nojiri_shuko@lilly.com
authors.forename: Shuko
authors.initials: S
authors.lastname: Nojiri
authors.forename: Russel T
authors.initials: RT
authors.lastname: Burge
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Flynn
authors.forename: Shonda A
authors.initials: SA
authors.lastname: Foster
authors.forename: Hideaki
authors.initials: H
authors.lastname: Sowa
mesh_terms: D050723:Fractures, Bone / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D010024:Osteoporosis / Q000188:drug therapy* / Q000453:epidemiology* / Q000401:mortality; D012307:Risk Factors
references.citation: J Bone Miner Res. 2000 Apr;15(4):721-39
references.pmid: 10780864
references.citation: Drugs Aging. 2012 Mar 1;29(3):191-203
references.pmid: 22372723
references.citation: Osteoporos Int. 2010 Jan;21(1):71-9
references.pmid: 19499274
references.citation: J Bone Miner Metab. 2008;26(4):373-8
references.pmid: 18600404
references.citation: Osteoporos Int. 2004 Nov;15(11):897-902
references.pmid: 15490120
references.citation: Osteoporos Int. 2012 Apr;23(4):1381-90
references.pmid: 21927926
references.citation: Osteoporos Int. 2003 Dec;14(12):1007-12
references.pmid: 14557854
references.citation: Osteoporos Int. 2006 Feb;17(2):313-6
references.pmid: 16217588
references.citation: Curr Med Res Opin. 2011 Jun;27(6):1273-84
references.pmid: 21554143
references.citation: J Bone Miner Res. 2002 Jul;17(7):1237-44
references.pmid: 12096837
references.citation: Lancet. 2009 Oct 3;374(9696):1196-208
references.pmid: 19801098
references.citation: Int J Epidemiol. 1995 Dec;24(6):1171-7
references.pmid: 8824859
references.citation: J Bone Miner Res. 1997 Jul;12(7):998-1004
references.pmid: 9199997
references.citation: N Engl J Med. 2001 May 10;344(19):1434-41
references.pmid: 11346808
references.citation: JAMA. 1999 Aug 18;282(7):637-45
references.pmid: 10517716
references.citation: Yonsei Med J. 2008 Feb 29;49(1):119-28
references.pmid: 18306478
references.citation: J Bone Miner Metab. 2010;28(1):55-9
references.pmid: 19582539
references.citation: Osteoporos Int. 2009 Aug;20(8):1429-37
references.pmid: 19101754
references.citation: Osteoporos Int. 2002 Dec;13(12):971-9
references.pmid: 12459940
references.citation: J Bone Miner Metab. 2008;26(1):34-41
references.pmid: 18095061
references.citation: J Bone Miner Res. 2009 Jun;24(6):1095-102
references.pmid: 19113931
references.citation: Osteoporos Int. 2009 May;20(5):695-702
references.pmid: 18836672
references.citation: Osteoporos Int. 2009 Apr;20(4):543-8
references.pmid: 18633667
references.citation: Arch Osteoporos. 2009 Dec;4(1-2):71-77
references.pmid: 20234789
references.citation: Bone. 2010 Sep;47(3):493-502
references.pmid: 20580870
references.citation: Osteoporos Int. 2005 Oct;16(10):1239-46
references.pmid: 15729479
references.citation: J Bone Miner Res. 2003 Aug;18(8):1547-53
references.pmid: 12929946
references.citation: Obstet Gynecol. 2004 Oct;104(4):837-44
references.pmid: 15458908
references.citation: Arthritis Rheum. 2002 Dec 15;47(6):651-4
references.pmid: 12522840
references.citation: Osteoporos Int. 2002 Sep;13(9):723-30
references.pmid: 12195536
references.citation: Curr Rheumatol Rep. 2003 Feb;5(1):65-74
references.pmid: 12590887
references.citation: Osteoporos Int. 2009 Sep;20(9):1613-20
references.pmid: 19137351
references.citation: J Clin Endocrinol Metab. 2002 Aug;87(8):3609-17
references.pmid: 12161484
references.citation: Intern Med. 2011;50(5):397-404
references.pmid: 21372448
references.citation: J Bone Miner Res. 2008 Dec;23(12):1923-34
references.pmid: 18665787
references.citation: J Bone Miner Metab. 2006;24(2):100-4
references.pmid: 16502115
references.citation: J Bone Miner Metab. 2009;27(5):620-8
references.pmid: 19568689
references.citation: J Bone Miner Res. 2008 Apr;23(4):525-35
references.pmid: 18072873
references.citation: Bone. 2007 Jun;40(6):1447-52
references.pmid: 17045858
references.citation: J Orthop Sci. 2010 Nov;15(6):737-45
references.pmid: 21116890
references.citation: Disabil Rehabil. 2010;32(10):826-35
references.pmid: 19817664
references.citation: Toxicol Pathol. 2002 May-Jun;30(3):312-21
references.pmid: 12051548
references.citation: J Bone Miner Res. 2005 Sep;20(9):1514-24
references.pmid: 16059623
references.citation: Bone. 2003 Jan;32(1):78-85
references.pmid: 12584039
references.citation: J Bone Miner Res. 2012 Dec;27(12):2429-37
references.pmid: 22991313
references.citation: J Bone Miner Res. 2007 Feb;22(2):334
references.pmid: 17129179
references.citation: J Bone Miner Metab. 2011 May;29(3):309-14
references.pmid: 20814705
references.citation: J Bone Miner Res. 2010 Nov;25(11):2267-94
references.pmid: 20842676
references.citation: Osteoporos Int. 2007 May;18(5):585-91
references.pmid: 17146592
references.citation: Bone. 2004 Aug;35(2):375-82
references.pmid: 15268886
references.citation: Osteoporos Int. 2006;17(7):986-95
references.pmid: 16552468
references.citation: J Orthop Sci. 2006 Oct;11(5):446-9
references.pmid: 17013730
references.citation: Mod Rheumatol. 2008;18(2):170-6
references.pmid: 18297237
references.citation: Nihon Rinsho. 1998 Jun;56(6):1563-8
references.pmid: 9648482
references.citation: Osteoporos Int. 2010 May;21(5):797-803
references.pmid: 19618096
references.citation: J Pharmacol Exp Ther. 2000 Nov;295(2):431-7
references.pmid: 11046073
references.citation: Bone. 2011 Sep;49(3):493-8
references.pmid: 21605715
references.citation: J Bone Miner Res. 2011 Mar;26(3):519-29
references.pmid: 20839291
references.citation: Osteoporos Int. 2009 Feb;20(2):187-95
references.pmid: 19096746
references.citation: J Orthop Sci. 2006 Mar;11(2):127-34
references.pmid: 16568383
references.citation: Bone. 2009 Jan;44(1):168-72
references.pmid: 19010116
references.citation: Bone. 2010 Dec;47(6):1064-70
references.pmid: 20832514
references.citation: J Craniomaxillofac Surg. 2011 Jun;39(4):272-7
references.pmid: 20580566
references.citation: Osteoporos Int. 2011 Jan;22(1):97-103
references.pmid: 20333358
references.citation: J Orthop Surg (Hong Kong). 2010 Aug;18(2):148-52
references.pmid: 20808003
references.citation: Clin Calcium. 2004 Mar;14(3):371-6
references.pmid: 15576994
references.citation: Jpn J Nurs Sci. 2010 Jun;7(1):96-107
references.pmid: 20618681
references.citation: Endocr J. 2011;58(8):613-24
references.pmid: 21778617
references.citation: J Bone Miner Metab. 2004;22(5):469-78
references.pmid: 15316868
references.citation: Curr Med Res Opin. 2009 Apr;25(4):921-8
references.pmid: 19250060
references.citation: Osteoporos Int. 2007 Oct;18(10):1397-403
references.pmid: 17460805
references.citation: J Bone Miner Res. 1993 Jul;8(7):861-9
references.pmid: 8352068
references.citation: BMC Fam Pract. 2006 May 09;7:31
references.pmid: 16684358
references.citation: Osteoporos Int. 2003 Oct;14(10):793-800
references.pmid: 12955333
references.citation: J Bone Miner Metab. 2002;20(5):311-8
references.pmid: 12203038
references.citation: Arch Intern Med. 2003 Sep 22;163(17):2052-7
references.pmid: 14504118
references.citation: Osteoporos Int. 2010 Sep;21(9):1513-22
references.pmid: 19924494
references.citation: Bone. 2009 Jun;44(6):1078-84
references.pmid: 19264155
references.citation: J Bone Miner Res. 2005 Sep;20(9):1507-13
references.pmid: 16059622
references.citation: Clin Rheumatol. 2011 Aug;30(8):1105-11
references.pmid: 21484222
references.citation: J Orthop Sci. 2010 Mar;15(2):192-7
references.pmid: 20358331
references.citation: Calcif Tissue Int. 2012 Jan;90(1):14-21
references.pmid: 22076525
references.citation: Osteoporos Int. 2010 Jun;21(6):1041-5
references.pmid: 19597911
references.citation: Osteoporos Int. 2004 Jul;15(7):560-6
references.pmid: 15067499
references.citation: Bone. 2011 Sep;49(3):520-5
references.pmid: 21652001
references.citation: J Bone Miner Metab. 2010;28(1):68-76
references.pmid: 19633810
references.citation: J Bone Miner Metab. 2010 Mar;28(2):233-9
references.pmid: 19806302